1. Effect of once‐weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c. Issue 2 (5th October 2017) Authors: Gallwitz, Baptist; Dagogo‐Jack, Samuel; Thieu, Vivian; Garcia‐Perez, Luis‐Emilio; Pavo, Imre; Yu, Maria; Robertson, Kenneth E.; Zhang, Nan; Giorgino, Francesco Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 2(2018) Page Start: 409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study. Issue 1 (9th December 2019) Authors: Mody, Reema; Huang, Qing; Yu, Maria; Patel, Hiren; Zhang, Xian; Wang, Liya; Grabner, Michael Journal: BMJ open diabetes research and care Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon‐like peptide‐1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once‐weekly exenatide and liraglutide. Issue 7 (16th March 2017) Authors: Alatorre, Carlos; Fernández Landó, Laura; Yu, Maria; Brown, Katelyn; Montejano, Leslie; Juneau, Paul; Mody, Reema; Swindle, Ralph Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 7(2017) Page Start: 953 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Artificial infiltration in drinking water production: Addressing chemical hazards using effect-based methods. (1st August 2022) Authors: Yu, Maria; Mapuskar, Shreya; Lavonen, Elin; Oskarsson, Agneta; McCleaf, Philip; Lundqvist, Johan Journal: Water research Issue: Volume 221(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the United States. (2nd November 2022) Authors: Mody, Reema; Meyers, Juliana; Yu, Maria; Davis, Keith; Levine, Joshua A. Journal: Current medical research and opinion Issue: Volume 38:Number 11(2022) Page Start: 1785 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Adherence and persistence among patients with type 2 diabetes initiating dulaglutide compared with semaglutide and exenatide BCise: 6‐month follow‐up from US real‐world data. Issue 1 (11th October 2020) Authors: Mody, Reema; Yu, Maria; Nepal, Bal; Konig, Manige; Grabner, Michael Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 1(2021) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER). Issue 3 (19th December 2019) Authors: Matza, Louis S.; Boye, Kristina S.; Stewart, Katie D.; Coyne, Karin S.; Wullenweber, Paula K.; Cutts, Katelyn N.; Jordan, Jessica B.; Wang, Qianqian; Yu, Maria; Currie, Brooke M.; Malley, Karen G.; Ishak, K. Jack; Hietpas, Ryan T.; García‐Pérez, Luis‐Emilio Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 3(2020) Page Start: 355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cover Image, Volume 22, Issue 3. Issue 3 (18th February 2020) Authors: Matza, Louis S.; Boye, Kristina S.; Stewart, Katie D.; Coyne, Karin S.; Wullenweber, Paula K.; Cutts, Katelyn N.; Jordan, Jessica B.; Wang, Qianqian; Yu, Maria; Currie, Brooke M.; Malley, Karen G.; Ishak, K. Jack; Hietpas, Ryan T.; García‐Pérez, Luis‐Emilio Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 3(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Adherence, persistence, glycaemic control and costs among patients with type 2 diabetes initiating dulaglutide compared with liraglutide or exenatide once weekly at 12‐month follow‐up in a real‐world setting in the United States. Issue 4 (9th January 2019) Authors: Mody, Reema; Huang, Qing; Yu, Maria; Zhao, Ruizhi; Patel, Hiren; Grabner, Michael; Landó, Laura Fernández Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 4(2019) Page Start: 920 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Effect of once‐weekly dulaglutide versus insulin glargine in people with type 2 diabetes and different baseline glycaemic patterns: A post hoc analysis of the AWARD‐2 clinical trial. Issue 11 (16th August 2019) Authors: Giorgino, Francesco; Yu, Maria; Haupt, Axel; Milicevic, Zvonko; García‐Pérez, Luis‐Emilio Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 11(2019) Page Start: 2570 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗